vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Noble Corp plc (NE). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $764.4M, roughly 1.2× Noble Corp plc). Noble Corp plc runs the higher net margin — 11.3% vs 0.7%, a 10.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -17.6%). Noble Corp plc produced more free cash flow last quarter ($35.4M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 9.5%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.

ASTH vs NE — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.2× larger
ASTH
$950.5M
$764.4M
NE
Growing faster (revenue YoY)
ASTH
ASTH
+60.5% gap
ASTH
42.9%
-17.6%
NE
Higher net margin
NE
NE
10.6% more per $
NE
11.3%
0.7%
ASTH
More free cash flow
NE
NE
$41.3M more FCF
NE
$35.4M
$-6.0M
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
9.5%
NE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTH
ASTH
NE
NE
Revenue
$950.5M
$764.4M
Net Profit
$6.6M
$86.6M
Gross Margin
Operating Margin
1.9%
5.6%
Net Margin
0.7%
11.3%
Revenue YoY
42.9%
-17.6%
Net Profit YoY
184.4%
-10.4%
EPS (diluted)
$0.12
$0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
NE
NE
Q4 25
$950.5M
$764.4M
Q3 25
$956.0M
$798.0M
Q2 25
$654.8M
$848.7M
Q1 25
$620.4M
$874.5M
Q4 24
$665.2M
$927.3M
Q3 24
$478.7M
$800.5M
Q2 24
$486.3M
$692.8M
Q1 24
$404.4M
$637.1M
Net Profit
ASTH
ASTH
NE
NE
Q4 25
$6.6M
$86.6M
Q3 25
$373.0K
$-21.1M
Q2 25
$9.4M
$42.9M
Q1 25
$6.7M
$108.3M
Q4 24
$-7.8M
$96.6M
Q3 24
$16.1M
$61.2M
Q2 24
$19.2M
$195.0M
Q1 24
$14.8M
$95.5M
Operating Margin
ASTH
ASTH
NE
NE
Q4 25
1.9%
5.6%
Q3 25
2.0%
6.3%
Q2 25
3.1%
15.9%
Q1 25
3.3%
21.4%
Q4 24
0.1%
18.4%
Q3 24
5.9%
14.4%
Q2 24
6.2%
30.3%
Q1 24
7.5%
16.9%
Net Margin
ASTH
ASTH
NE
NE
Q4 25
0.7%
11.3%
Q3 25
0.0%
-2.6%
Q2 25
1.4%
5.1%
Q1 25
1.1%
12.4%
Q4 24
-1.2%
10.4%
Q3 24
3.4%
7.6%
Q2 24
3.9%
28.1%
Q1 24
3.7%
15.0%
EPS (diluted)
ASTH
ASTH
NE
NE
Q4 25
$0.12
$0.54
Q3 25
$0.01
$-0.13
Q2 25
$0.19
$0.27
Q1 25
$0.14
$0.67
Q4 24
$-0.14
$0.56
Q3 24
$0.33
$0.40
Q2 24
$0.40
$1.34
Q1 24
$0.31
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
NE
NE
Cash + ST InvestmentsLiquidity on hand
$429.5M
$471.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$4.5B
Total Assets
$2.2B
$7.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
NE
NE
Q4 25
$429.5M
$471.4M
Q3 25
$463.4M
$477.9M
Q2 25
$342.1M
$338.2M
Q1 25
$260.9M
$303.8M
Q4 24
$290.8M
$247.3M
Q3 24
$350.3M
$391.9M
Q2 24
$327.7M
$162.9M
Q1 24
$337.3M
$212.5M
Stockholders' Equity
ASTH
ASTH
NE
NE
Q4 25
$779.3M
$4.5B
Q3 25
$775.5M
$4.5B
Q2 25
$765.5M
$4.6B
Q1 25
$745.4M
$4.7B
Q4 24
$712.7M
$4.7B
Q3 24
$704.6M
$4.7B
Q2 24
$678.9M
$4.0B
Q1 24
$653.5M
$3.9B
Total Assets
ASTH
ASTH
NE
NE
Q4 25
$2.2B
$7.5B
Q3 25
$2.2B
$7.6B
Q2 25
$1.4B
$7.7B
Q1 25
$1.3B
$7.9B
Q4 24
$1.4B
$8.0B
Q3 24
$1.3B
$8.0B
Q2 24
$1.3B
$5.6B
Q1 24
$1.2B
$5.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
NE
NE
Operating Cash FlowLast quarter
$-2.9M
$187.1M
Free Cash FlowOCF − Capex
$-6.0M
$35.4M
FCF MarginFCF / Revenue
-0.6%
4.6%
Capex IntensityCapex / Revenue
0.3%
19.9%
Cash ConversionOCF / Net Profit
-0.44×
2.16×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$432.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
NE
NE
Q4 25
$-2.9M
$187.1M
Q3 25
$10.0M
$277.1M
Q2 25
$90.9M
$216.4M
Q1 25
$16.6M
$271.1M
Q4 24
$-10.9M
$136.2M
Q3 24
$34.0M
$283.8M
Q2 24
$23.2M
$106.8M
Q1 24
$6.0M
$128.7M
Free Cash Flow
ASTH
ASTH
NE
NE
Q4 25
$-6.0M
$35.4M
Q3 25
$7.4M
$139.5M
Q2 25
$89.5M
$99.8M
Q1 25
$13.6M
$157.5M
Q4 24
$-13.5M
$-4.4M
Q3 24
$31.7M
$156.8M
Q2 24
$20.4M
$-34.3M
Q1 24
$5.6M
$-37.9M
FCF Margin
ASTH
ASTH
NE
NE
Q4 25
-0.6%
4.6%
Q3 25
0.8%
17.5%
Q2 25
13.7%
11.8%
Q1 25
2.2%
18.0%
Q4 24
-2.0%
-0.5%
Q3 24
6.6%
19.6%
Q2 24
4.2%
-4.9%
Q1 24
1.4%
-6.0%
Capex Intensity
ASTH
ASTH
NE
NE
Q4 25
0.3%
19.9%
Q3 25
0.3%
17.3%
Q2 25
0.2%
13.7%
Q1 25
0.5%
13.0%
Q4 24
0.4%
15.2%
Q3 24
0.5%
15.9%
Q2 24
0.6%
20.4%
Q1 24
0.1%
26.2%
Cash Conversion
ASTH
ASTH
NE
NE
Q4 25
-0.44×
2.16×
Q3 25
26.69×
Q2 25
9.65×
5.05×
Q1 25
2.48×
2.50×
Q4 24
1.41×
Q3 24
2.11×
4.64×
Q2 24
1.21×
0.55×
Q1 24
0.40×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

NE
NE

Floaters$559.8M73%
Jackups$145.5M19%
Service Other$59.1M8%

Related Comparisons